October 29, 2014

Consumers want to know: do disinfectant products like Reckitt Benckiser's Lysol or Clorox protect against the Ebola virus?

October 28, 2014

The Retail Orphan Initiative on Tuesday hosted a webinar detailing a major charitable campaign to fight Ebola in Liberia.

October 27, 2014

Responding to the Ebola virus epidemic, the Retail Orphan Initiative on Monday announced a major campaign to help fight Ebola in Liberia. 

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 23, 2014

GlaxoSmithKline expects to have its Ebola vaccine available by year's end.

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

October 16, 2014
AdAge on Thursday attributed higher sales of hand sanitizer and disinfectants to the rise in Ebola-related media reports.
October 14, 2014

Cardinal Health on Tuesday announced it had recently donated more than 1 million products to AmeriCares Emergency Response Program to help contain the deadly Ebola outbreak in West Africa. 

October 10, 2014

The Food and Drug Administration on Friday approved Gilead's Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus genotype 1 infection.

October 9, 2014

At a time when nearly every media outlet is covering Ebola, Enterovirus D-68, or a new outbreak of an infectious disease, the American Pharmacists Association is reminding Americans that the nation’s pharmacists are ready to help.

October 8, 2014

The dietary supplement industry on Tuesday spoke out against any supplement manufacturer making advertising claims around the Ebola virus.

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 6, 2014

FloraTummys is a new probiotic especially made for kids rather than a line extension of the adult probiotic.

October 3, 2014

Biolife is helping to combat the Ebola issue with the donation of its WoundSeal product, which helps stop bleeding and seals wounds, to Africa, according to a report from ABC affiliate WWSB

 

September 24, 2014

Probi and Pharmavite entered into a long-term agreement for the distribution and marketing of Probi's line of probiotic products.

September 1, 2014

Pfizer last week announced that the Food and Drug Administration has granted fast track designation to the company’s investigational Clostridium difficile (C. difficile) vaccine candidate (PF-06425090). 

August 21, 2014

Hospitals and state laboratories in the United States have processed more than 60 Ebola scares over the course of the last few weeks, according to a report from ABC News.

 

August 20, 2014

Carma Labs on Wednesday announced the launch of Carmex Cold Sore Treatment. 

August 15, 2014

Pfizer’s Prevnar 13 vaccine for pneumonia has been recommended for use by patients 65 years old and up by the Centers for Disease Control and Prevention’s immunization practices advisory committee. 

August 14, 2014

Pragma Pharmaceuticals announced the relaunch of Moxatag (amoxicillin extended-release tablets), 775 mg.

August 7, 2014

A new experimental drug to treat Ebola has been tried in the two American patients being treated in an Atlanta hospital, The New York Times reported Wednesday

August 5, 2014

New York City's Department of Health and Mental Hygiene said a man who was tested for Ebola at Mount Sinai Hospital is "unlikely" to have the virus. The patient was admitted to the hospital early Monday with a fever and gastrointestinal problems. He recently visited a West African country where Ebola was reported, according to the Washington Post.

July 21, 2014

Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.

July 14, 2014

Pure Encapsulations recently launched PureBiOme, a line of probiotics using proprietary PureBiOme freeze-drying technology, which enables probiotics to maintain potency when combined with active ingredients for the first time.